Rendimento dei dividendi di BioNeutra Global Corporation è N/A
Il rendimento dei dividendi rappresenta il rapporto tra i dividendi distribuiti agli azionisti per azione e il prezzo di mercato per azione nel corso di un anno finale.
The dividend yield or dividend-price ratio of a share is the dividend per share, divided by the price per share. It is also a company's total annual dividend payments divided by its market capitalization, assuming the number of shares is constant, and is often expressed as a percentage. The reciprocal of the dividend yield is the price-dividend ratio.
A higher dividend yield has been considered to be desirable among many investors. A high dividend yield can be considered to be evidence that a stock is underpriced or that the company has fallen on hard times and future dividends will not be as high as previous ones. Similarly a low dividend yield can be considered evidence that the stock is overpriced or that future dividends might be higher. Some investors may find a higher dividend yield attractive, for instance as an aid to marketing a fund to retail investors, or maybe because they cannot get their hands on the capital, which may be tied up in a trust arrangement. In contrast some investors may find a higher dividend yield unattractive, perhaps because it increases their tax bill.
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.